Supplier Type
- Manufacturer
- Reagent
- Trader
- custom synthesis
- contract manufacturer
Supplier Region
- Hyderabad(25)
- Bangalore(3)
- Gujarat(20)
- Maharashtra(23)
- Tamil Nadu(1)
- New Delhi(4)
- Mumbai(36)
- Andhra Pradesh(3)
- Delhi(9)
- Vadodara(13)
- Ahmedabad(8)
- Telangana(3)
- Pune(4)
- Karnataka(6)
- Kolkata(2)
- Madhya Pradesh(3)
- Rajasthan(1)
- Uttar Pradesh(4)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Pure
- Potassium content 15.5 - 17.5
- NLT 98%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Magnesium content 8.49% to 8.84%
- lemon-lime grade (purity, 70%), a clear water-white ...
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Chemically Pure
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.98%
- 99.95%
- 99.91%
- 99.86%
- 99.85%
- 99.83%
- 99.8%
- 99.73%
- 99.50%
- 99.5%
- 99.47%
- 99.42%
- 99.29%
- 99.23%
- 99.2%
- 99.05%
- 99.00%
- 99.0% e.e. Min
- 99.0%
- 99% Minimum
- >99%
- 99%
- > 99%
- 98+
- 98.85%
- 98.60%
- 98.5 to 101.5%
- 98.12%
- 98.00%
- 98%+
- >98%
- 98%
- 98 %
- 97-99%
- 97.57%
- 97%
- >97%
- 97 %
- 96.80%
- 96.40%
- 96.39%
- 96.00 % Min
- 96%
- 95.00%
- 95.00 % Min
- 95% min
- >95%
- 95%
- 94.84%
- 94.25%
- 94.00%
- 93.0 % Min
- 93 %- 101%
- 92.55%
- >92%
- 90-95%
- >90%
- 90%
- 90 % Min.
- 90 % Above
- 75 %
- 68.0 % Min
- 65%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- 1gm
- 1000mg
- 5g
- 10g
- 10Gram
- 25g
- 50g
- 100gm
- 100g
- 500gm
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
-
Atorvastatin Related Compound D (20 mg) (Epoxide impurity, or 3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyl-oxirane-2- carboxylic acid phenylamide)
148146-51-4
-
1-Methylindazole-3-carboxylic acid
50890-83-0
-
4-(Aminomethyl)benzoic acid
56-91-7
-
2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil
1185256-03-4
-
3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane
158401-52-6
-
Montelukast Bis-sulfide (Mixture of Diastereomers)
1187586-61-3
-
Montelukast EP IMpurity E
1187586-58-8
-
ent-Voriconazole
137234-63-0
-
Paroxetine Impurity 45
1396174-70-1
Atorvastatin Related Compound-D/Atorvastatin EP Impurity D 148146-51-4
Atorvastatin ep impurity D 148146-51-4
ATORVASTATIN EP IMPURITY D 148146-51-4
4-Fluorophenylboronic acid 1765-93-1
4-Amino-1H-pyrazolo[3,4-d]pyrimidine 2380-63-4
Atorvastatin 134523-00-5
(5S)-D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl 1103738-19-7
D-Norpseudoephedrine 492-39-7
Montelukast acyl-b-D-glucuronide 188717-17-1
ALPHA-D-Glucose 492-62-6